<DOC>
	<DOCNO>NCT01392638</DOCNO>
	<brief_summary>Sildenafil citrate slightly reduce blood pressure treat hypertensive patient . However , unknown simultaneous use sildenafil plus , least , 3 class antihypertensive agent patient resistant arterial hypertension may synergic effect patient blood pressure . Moreover , sildenafil improves endogen nitric oxide effect . The nitric oxide important signal molecule body contribute vessel homeostasis inhibit vascular smooth muscle contraction growth . Hypertension often impair NO pathway . Nitric oxide produce enzyme , call nitric oxide synthase ( NOS3 ) , show genetics variant , mean enzyme different person person . Therefore , objective present study examine influence genetic variant ( know affect NOS3 level ) sildenafil acute effect hemodynamic cardiovascular function . The investigator hypothesis individual genetic variant associate high level NOS3 benefit sildenafil treatment .</brief_summary>
	<brief_title>Effects Sildenafil Resistant Hypertensives Genetic Polymorphism</brief_title>
	<detailed_description>Endothelial dysfunction one mechanism involve maintenance high blood pressure level resistants hypertensives patient , directly relate NO-GMPc pathway . The phosphodiesterase 5 inhibitor , sildenafil citrate , slightly reduce systolic diastolic blood pressure treat hypertensive patient . However , unknown simultaneous use sildenafil plus , least , 3 class antihypertensive agent patient resistant arterial hypertension may synergic effect patient blood pressure . Moreover , sildenafil improves endogen nitric oxide effect produce eNOS . Therefore , since genetics polymorphisms eNOS affect NO tissue level , seem reasonable suppose acute effect sildenafil may modulate . Objective : To examine influence T-786C polymorphism eNOS gene sildenafil acute effect hemodynamic cardiovascular function resistant hypertensives patient . Casuistics Methods : Around 120 patient HAR genotyped T-786C eNOS polymorphism , investigator enroll study 15 patient TT genotype 15 patient CC genotype . The patient monitor Portapres system ( non-invasive hemodynamic ) . After basal record study variable , increase dos sildenafil administrate ( 37.5 , 50.0 e 100.0 mg ) . Five minute new dose , study variable record . Hypothesis : The investigator hypothesize sildenafil , besides anti-ischemic effect , improve patient hemodynamic status , moreover , occur modulation effect T-786C polymorphism .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>resistant hypertensive ( accord Resistant Hypertension AHA Statement 2008 ) ; compliance antihypertensive treatment ; age &gt; 35 year ; diastolic dysfunction valvulopathy decompensated heart failure important cardiac arrhythmia nephropathy hepatopathy autoimmune disease tabagism decompensated diabetes uncontrolled dislipidemia</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Sildenafil</keyword>
	<keyword>Nitric oxide synthase</keyword>
	<keyword>Polymorphism</keyword>
	<keyword>Hemodynamics</keyword>
</DOC>